Previous work has shown that the 0.02-0.05% of adult mouse bone marrow cells that bear the cell surface phenotype Thy 1IoLin-Sca-l+ are enriched 1000-to 2000-fold for hematopoietic stem-cell activity in a variety of assays. When 50-100 cells of this phenotype are iijected into an irradiated animal, they can permanently repopulate the entire hematopoietic system. In the present study, limiting-dilution and single-cell experiments were used to address the question of how individual Thy-11OLin-Sca-1+ stem cells contribute to repopulation of the hematopoietic system following irradiation. We calculated that 1 of 13 Thy-loLin-Sca-l+ cells formed a clone comprising >1% of peripheral white blood cells 3-7 weeks after injection. The majority of these clones included both lymphoid and myeloid lineages. Approximately one-third of the clones continued to produce new blood cells for 9 weeks or more, but the remainder disappeared earlier, including many that were multilineage. Thus, while the majority of Thy-1IOLin-Sca-l+ bone marrow cells whose progeny are detected in the in vivo repopulation assay are pluripotential, only a subset undergo long-term self-renewal in vivo. Repopulation appears to be oligoclonal when limiting numbers of Thy-1IOLin-Sca-l+ cells are injected. However, the number of clones contributing to hematopoiesis increases in proportion to the number of Thy-1IOLin-Sca-l+ cells i 'ected, bringing into question the notion that steady-state hematopoiesis in normal individuals is oligoclonal.
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All cell lineages of the blood system are derived from pluripotential hematopoietic stem cells (PHSCs), a rare class of cells that reside in the bone marrow of adult vertebrates (1) . Blood cell lineages are transient, with half-lives ranging from hours (e.g., granulocytes) to months (e.g., lymphocytes), and must therefore be generated continuously throughout the life ofthe animal (2) . How PHSCs individually contribute to this overall outcome is not well understood.
Because of their low frequency in the bone marrow (10'-to 10-5, depending on the method used to assay PHSCs; refs. [3] [4] [5] [6] , these cells have been difficult to study directly. Most work on this problem has relied on the ability to study clones elaborated from marked cells of unknown identity in bone marrow or fetal liver (e.g., refs. [7] [8] [9] [10] . Previous work has demonstrated that adult mouse bone marrow cells (BMCs) expressing Sca-1 (Ly-6A) and low levels of Thy-1 but lacking expression of several other hematopoietic lineage markers (Thy-1loLin-Sca-1+) are enriched 1000-to 2000-fold compared with unseparated BMCs for PHSC activity in a variety of assays (11) (12) (13) . As few as 30 Thy-1VoLin-Sca-1+ BMCs can rescue 50% of lethally irradiated mice and repopulate the hematopoietic system of the host. To characterize Thy-1io
Lin-Sca-1+ stem cells more precisely, and to study the clonal organization of hematopoietic repopulation by this defined cell population, we have assessed the developmental potential of single Thy-11oLin-Sca-1+ cells in vivo by two methods.
We developed a limiting-dilution system that allows us to trace the progeny of individual Thy-1loLin-Sca-l+ cells with high probability. In addition we injected single Thy-1Io Lin-Sca-1l cells [isolated by fluorescence-activated cell sorter (FACS)] into irradiated mice and observed the clones they produced. Our results indicate that individual Thy-110
Lin-Sca-1l cells produce multilineage clones of variable size and life-span. The number of clones contributing to hematopoiesis in any one irradiated host appears to depend on the number of Thy-11oLin-Sca-1+ cells injected, at least within the first 1-2 months after irradiation. These results are discussed in relation to previous studies on the clonal organization of hematopoiesis.
MATERIALS AND METHODS
Mouse Strains. Donor and host mice were either C57BL or congenic with this strain and were bred and maintained in the mouse facilities at Stanford University or SyStemix. Donor/ host strain combinations are summarized in Table 1 .
BMC Separation and Construction of Radiation Chimeras. analyzed using the binomial equation (18) P(r) = [n!lr!(n -r)!] prq(n-r). P(r) is the probability that r clones will form from n marked Thy-1IoLin-Sca-1+ cells, of which each has a probability p of forming a clone and a probability q of not forming a clone (p = 1 -q). The probability that a mouse will be negative (i.e., r = 0) reduces to log P(0) = n log q.
Thus, if q is fixed, then a linear relationship (with the slope of log q) will exist between the logarithm of the proportion of negative mice in a group and the number of cells injected. Values of P(0) and n can thus be used to calculate p and q for each experimental group. The value of 1/13 for p is a weighted mean of the values obtained for each experimental group plotted in Fig. 1 . The probability that positive mice in any one group will be repopulated by one and only one marked clone can be calculated from the binomial equation by using the calculated values for p and q (1/13 and 12/13, respectively). To do this, the probability P(1) (i.e., r = 1) is divided by the sum P(1) + P(2) + P(3) + P(4) + P(5) (i.e., r . 1). If marked and unmarked Thy-11OLin-Sca-1+ cells have equal probabilities of forming clones, then the mean of the total number of clones (marked and unmarked) contributing to hematopoiesis is p x n, where n now represents the total number of cells injected, i.e., 8 for 105 cells injected, 8.5 for 110 cells injected, and 9.2 for 120 cells injected. Data shown in Fig. 3 B and C were analyzed by the Kruskall-Wallis analysis of variance of ranks (18) .
RESULTS
Limiting-dilution experiments were performed initially to determine the frequency of FACS-sorted Thy-1l°Lin-Sca-1+ cells that can contribute to hematopoiesis when injected into a lethally irradiated host. Limiting numbers of Thy-11o-Lin-Sca-1+ cells (5-20 cells) were injected into lethally irradiated host mice together with a minimum dose of stem cells necessary for near 100% host survival: either 105 unseparated BMCs (Exps. 1 and 2) or 100 Thy-loLin-Sca-l+ cells (Exps. 3 and 4) from a different donor. To mark progeny of the limiting number of Thy-1IoLin-Sca-1+ cells, we made use of congenic mouse strains carrying different alleles of Ly-5 on the C57BL background. Ly-5 is a polymorphic cell surface antigen found on all mature leukocytes (19) . Monoclonal antibodies specific for Ly-5.1 and Ly-5.2 allowed us to distinguish progeny of the 5-20 Thy-1loLin-Sca-1+ cells from the progeny of the other stem cells and the host. Donor/host combinations are summarized in Table 1 . Peripheral blood of recipient animals was screened 3-4 and 6-7 weeks later for cells carrying the Ly-5 marker, and simultaneously stained with antibodies that define mature T lymphocytes, B lymphocytes, and myeloid lineages.
An approximately linear relationship was observed between the number of marked Thy-loLin-Sca-l+ cells injected and the proportion (logarithmic scale) of mice that were negative for marked cells in peripheral blood 3-7 weeks later. Pooled results of four independent experiments are shown in Fig. 1 . We analyzed these data with the binomial equation, assuming that there is a probability, p, that an injected Thy-1IoLin-Sca-1+ cell will form a clone; p will be influenced by factors such as heterogeneity in the clonogenic potential ofThy-11oLin-Sca-l+ cells and seeding efficiency to appropriate sites in the bone marrow. We calculated that 1 of 13 sorted Thy-11OLin-Sca-l+ cells forms a clone comprising >1% of circulating white blood cells 3-7 weeks after injection into irradiated hosts. The probability that marked cells in the Table 3 summarizes data on the composition and life-span ofthe clones obtained by single-cell injection and the putative clones obtained after injection of five cells. The two types of experiments gave comparable spectra of repopulation events, supporting the conclusion that the repopulation observed in most of the positive "five-cell" mice was indeed clonal. The clones varied widely in size. The peak clone size, usually reached at 4-6 weeks, varied from 65% of peripheral white blood cells for the largest clone to 1% for the smallest, which was the threshold of detection. Despite their variable sizes, the majority of the clones included all lineages we looked for (B and T lymphocytes, granulocytes, and monocytes), and all but three included at least two lineages. An example of a multilineage clone is shown in Fig. 2 . Lymph node cells from single-cell mouse C7 were analyzed 8 weeks postinjection. The contour plots demonstrate that C7 lymph nodes contained donor cells that were B220' (B cells), GR-1+ and/or Mac-1+ (granulocytes and monocytes), and CD4+ or CD8+ (T cells). The only clones that appeared to lack some lineages were very small, so it is possible that the "missing" lineages fell below the limit of detection but were nevertheless present. Thus we conclude that most, if not all, Thy-1lo Lin-Sca-1+ cells whose progeny are detected in this assay are capable of both myeloid and lymphoid differentiation.
The clones also exhibited variable life-spans. In assessing clone life-span, we concentrated on myeloid lineages because they are shorter-lived than lymphocytes, circulating on average <24 hr before leaving the bloodstream (2). Their presence in peripheral blood thus reflects continued production from stem and progenitor cells in the bone marrow. Donor myeloid cells continued to be produced for -9 weeks in about one-third of the repopulated animals (Table 3) . Without exception, myeloid cells stopped being produced before 9 weeks in the smallest clones (peak size < 8%). In addition, some of the larger clones, including two with peak sizes > 25%, also exhibited short life-spans (<9 weeks). Clone life-span was thus not tightly correlated with peak size. Many of the clones with short life-spans were multilineage.
While continued production of mature myeloid progeny is probably an indicator of stem-cell self-renewal, we attempted to measure self-renewal more directly in four single-cell-repopulated mice by secondary transfer 8 weeks after injection. Long-term multilineage repopulation of secondary hosts could occur only if the single stem cell injected had undergone self-renewal. The four mice tested were those repopulated by multilineage clones (see Table 2 ). Secondary transfer was successful with both total BMCs (5 x 106 to each of four hosts) and FACS-sorted, Ly-5-marked bone marrow cells (1.5 x 1 to each of three hosts) from C7. All C7 secondary hosts exhibited repopulation by Ly-5-marked myeloid, T, and B lineages, and the majority showed continued production of Ly-5-marked myeloid cells for at least 1 year. Bone marrow from the remaining three mice tested (nos. 63, 41, and 11), which had all stopped producing Ly-5-marked my- eloid cells by 8 weeks, showed no significant repopulation of any secondary hosts. We conclude that while the majority of Thy-lILin-Sca-1+ BMCs whose progeny can be detected in this in vivo repopulation assay are pluripotential, only a subset undergo extensive self-renewal. The conclusions of the experiments presented so far are largely consistent with work by others demonstrating that the hematopoietic system can be repopulated by small numbers of stem cells after irradiation (7) (8) (9) (10) . Oligoclonal repopulation has usually been interpreted in terms of a selective process in which a few stem cells are active at a time, while others are held in reserve. However, it is possible that oligoclonal repopulation simply results from the engraftment of a limited number of stem cells. To address this possibility, we tested the effect of stem-cell dose on the number of clones contributing to hematopoiesis and on their sizes. If the total number of clones contributing to hematopoiesis is relatively fixed, then increasing the size of the available stem-cell pool should reduce the probability that any individual stem cell will give rise to mature progeny. For a given limiting number of marked stem cells in the pool, this would result in a lower frequency of positive animals as the number of unmarked competitors increases, while individual clone sizes should remain unchanged. Alternatively, if the number of contributing clones increases in proportion to the stem-cell dose, then the frequency should not change, but clone sizes should generally decrease. These predictions were directly tested. Competitive repopulation experiments were carried out in which the number of marked Thy-11oLin-Sca-l+ cells was held constant at 25 cells while the number of unmarked Thy-1IoLin-Sca-1+ cells was varied from 100 to 1000. The dose of 25 donor cells was chosen because this number reliably gave 60-70% positive hosts when mixed with 100 other stem cells, and thus would allow measurement of any decreases in frequency in the presence of additional unmarked stem cells, as well as an analysis of the distribution of clone sizes. At this dose =50% of the positive animals are expected to have more than one marked clone contributing to repopulation. Pooled results of three independent experiments (Fig. 3A) demonstrate that increasing the total cell dose from 125 to 1025 does not alter the proportion of hosts in which one or more of the 25 marked Thy-11OLin-Sca-1+ cells have contributed to hematopoiesis. This indicates that the number of stem cells initially contributing to repopulation of the hematopoietic system after irradiation is not fixed but increases with the stem-cell dose. Assuming that marked and unmarked Thy-1l°Lin-Sca-1+ cells have equal probabilities offorming clones, we can estimate the mean numbers of stem cells contributing to hematopoiesis at each cell dose: 10 at 125, 25 at 325, and 79 at 1025. The effect of cell dose on clone size is shown for one of the experiments in Fig. 3B (at the 4-week time point) and Fig. 3C (8 weeks) . While the proportion of marked cells in positive mice for each cell dose is broadly distributed, the three distributions are significantly different at both time points (P < 0.05), showing an overall trend toward smaller clones at higher cell doses. While we cannot prove that this assumption is correct, our finding that the number of clones initially contributing to hematopoiesis after irradiation increases in direct proportion to the number of Thy-11OLin-Sca-1+ cells injected supports the assumption that the probability of any one Thy-11oLin-Sca-1+ cell contributing is fixed, -1/13, regardless of the cell dose. That the repopulating clones obtained after injection of single Thy-110
Lin-Sca-1+ cells showed the same range of properties (Table  3) further supports the conclusion that we were indeed observing clonal repopulation in most positive mice injected with five cells. The existence of rare stem cells capable of giving rise to both lymphoid and myeloid lineages has been known for some time (20) (21) (22) (23) (24) . In this report we have demonstrated that the majority of Thy-11OLin-Sca-1+ cells whose progeny are detected in the in vivo repopulation assay described have this ability. Other protocols have been defined for the enrichment of stem cells from adult bone marrow or fetal liver, using a variety of assays for stem-cell activity, including the ability to form discrete myeloerythroid colonies in the spleen of irradiated recipients, ability to protect mice from lethal irradiation, and ability to repopulate hematopoietic tissues after lethal irradiation (25) (26) (27) (28) (29) (30) . The variety of assays used creates some difficulty in comparing stem-cell-enriched populations prepared by different methods, but they are likely to be overlapping populations (reviewed in ref. 31 ). In some cases, the capacity ofother stem-cell-enriched populations to contribute to lymphoid lineages has been tested (28) (29) (30) , and in two cases, clonal markers revealed that single cells in these stem-cell-enriched populations had contributed to both lymphoid and myeloid lineages (29, 30) . However, in neither case was it possible to determine the frequency of pluripotential cells in the stem-cell-enriched population. To our knowledge, no other groups have demonstrated that single cells of defined phenotype can undergo myeloid and lymphoid differentiation at high frequency.
The Thy-11oLin-Sca-l+ cells formed clones of varying size and life-span (Table 3) . Clonal life-span was not tightly correlated with clone size. It is perhaps surprising that many multilineage clones were nevertheless very short-lived. However, in this respect and others, our results are largely in agreement with recent studies on the clonal organization of hematopoiesis, in which unique retroviral integration sites were used to mark clones of PHSC progeny (9, 10, 32) . In those studies, the number of repopulating clones was variable but relatively small (on the order of a few to a dozen). It was also found that the clones varied in size and life-span, some dying out within the first few months after irradiation whereas others persisted for many months. The spectrum of clones derived from Thy-1loLin-Sca-1+ cells appears to be comparable to those marked by retroviral integration sites, and thus the bone marrow stem-cell population marked by retrovirus in those studies (9, 10, 32 ) is likely to be at least overlapping with, if not identical to, the Thy-11oLin-Sca-l+ population.
While 1 in 13 Thy-1lOLin-Sca-1+ cells produced a detectable clone, only about one-third of these could be classified as both multilineage and long-term (producing myeloid cells for .9 weeks; Table 3 ). Thus, 1 in 39 Thy-11OLin-Sca-1+ cells was able to generate a long-term, multilineage clone in our assay system. Since Thy-11OLin-Sca-1+ cells are present at a frequency of 0.02-0.05% in adult bone marrow, this corresponds to a frequency of 0.5-1.3 per 105 adult BMCs. This frequency matches well with estimates of PHSC frequency in adult mouse bone marrow based on calculation of the number of clones contributing to long-term hematopoiesis after injection of irradiated recipients with graded numbers of adult BMCs: 1-3 per 105 (3, 4) . Estimates ofPHSC frequency based on other assays, such as the ability to protect mice from lethal doses of irradiation (5) or to "cure" genetically anemic WIWI mice (6) , have led to higher estimates of the frequency of stem cells in adult bone marrow, but these assays may not be exclusive for PHSCs with long-term repopulating ability. The formation of multilineage long-term clones by 1 in 39
Thy-11OLin-Sca-1+ cells is thus consistent with the hypothesis that all true PHSCs in normal adult bone marrow belong to this population.
The number of clones initially contributing to hematopoiesis after irradiation increased in direct proportion to the number of Thy-1loLin-Sca-1+ cells injected (Fig. 3) . This finding is in complete agreement with the conclusions of previous studies in which the number of clones contributing to hematopoiesis after irradiation was found to increase in direct proportion to the number of BMCs injected (3, 4, 33, 34) . Thus, in this respect Thy-1lOLin-Sca-1+ cells behave in a manner previously described for repopulating stem cells in unseparated bone marrow. This finding argues strongly against the possibility that repopulation of the hematopoietic system following irradiation results from the selection of a relatively fixed, small number of stem cells from the total available pool, regardless of how many are available. Indeed, this finding raises the intriguing question of how the number of stem cells contributing to hematopoiesis is determined. 
